Cargando…

Generalized Anxiety Disorder 7-Item (GAD-7) Scores in Medically Authorized Cannabis Patients—Ontario and Alberta, Canada

OBJECTIVES: Despite increasing rates of legalization of medical cannabis worldwide, the current evidence available on its effect on mental health outcomes including anxiety is of mixed results. This study assesses the effect of medical cannabis on generalized anxiety disorder 7-item (GAD-7) scores i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lee, Cerina, Round, Jessica M., Hanlon, John G., Hyshka, Elaine, Dyck, Jason R.B., Eurich, Dean T.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2021
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9149533/ https://www.ncbi.nlm.nih.gov/pubmed/34520280 http://dx.doi.org/10.1177/07067437211043393

Ejemplares similares

Gaps in evidence for the use of medically authorized cannabis: Ontario and Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Opioid use in medical cannabis authorization adult patients from 2013 to 2018: Alberta, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Cohort study of medical cannabis authorization and motor vehicle crash-related healthcare visits in 2014–2017 in Ontario, Canada
por: Lee, Cerina, et al.
Publicado: (2021)

Changes in patient health questionnaire (PHQ-9) scores in adults with medical authorization for cannabis
por: Round, Jessica M., et al.
Publicado: (2020)

Medical cannabis authorization and the risk of cardiovascular events: a longitudinal cohort study
por: Zongo, Arsene, et al.
Publicado: (2021)

Substance Use Disorders and Psychoactive Drug Poisoning in Medically Authorized Cannabis Patients: Longitudinal Cohort Study
por: Zongo, Arsène, et al.
Publicado: (2021)

Associations Between Canada's Cannabis Legalization and Emergency Department Presentations for Transient Cannabis-Induced Psychosis and Schizophrenia Conditions: Ontario and Alberta, 2015–2019
por: Callaghan, Russell C., et al.
Publicado: (2022)

Appropriateness of COVID-19 public health guidelines for an Alberta First Nations community
por: Soprovich, Allison L., et al.
Publicado: (2022)

Invasive Pneumococcal Disease and Long-Term Mortality Rates in Adults, Alberta, Canada
por: Versluys, Kristen A., et al.
Publicado: (2022)

Psychometric Properties of the General Anxiety Disorder 7-Item (GAD-7) Scale in a Heterogeneous Psychiatric Sample
por: Johnson, Sverre Urnes, et al.
Publicado: (2019)

Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine
por: Seo, Jong-Geun, et al.
Publicado: (2015)

Mental health experiences with COVID-19 public health measures in an Alberta First Nations Community
por: Lee, Cerina, et al.
Publicado: (2022)

Measurement Invariance of the GAD-7 and CESD-R-10 Among Adolescents in Canada
por: Romano, Isabella, et al.
Publicado: (2021)

Psychometric Properties of the Generalized Anxiety Disorder Scale-7 Item (GAD-7) in a Large Sample of Chinese Adolescents
por: Sun, Jiangang, et al.
Publicado: (2021)

Factorial structure, reliability, and construct validity of the Generalized Anxiety Disorder 7-item (GAD-7): Evidence from Malaysia
por: Pheh, Kai-Shuen, et al.
Publicado: (2023)

Completion of multiple-dose travel vaccine series and the availability of pharmacist immunizers: A retrospective analysis of administrative data in Alberta, Canada
por: Houle, Sherilyn K. D., et al.
Publicado: (2019)

Exploring the impact of pharmacist comprehensive annual care plans on perceived quality of chronic illness care by patients in Alberta, Canada
por: Necyk, Candace, et al.
Publicado: (2021)

Psychometric Properties of the 7-Item Generalized Anxiety Disorder (Gad-7) in Nigerian Pregnant Women Attending Primary Health Care
por: Olaluwoye, Oluwaseun, et al.
Publicado: (2023)

The Psychometric Properties and Clinical Utility of the Korean Version of GAD-7 and GAD-2
por: Ahn, Jung-Kwang, et al.
Publicado: (2019)

Frequent users of emergency departments and patient flow in Alberta and Ontario, Canada: an administrative data study
por: Chen, Anqi, et al.
Publicado: (2020)

Concurrent use of opioids and benzodiazepines/Z-drugs in Alberta, Canada and the risk of hospitalisation and death: a case cross-over study
por: Sharma, Vishal, et al.
Publicado: (2020)

Characterisation of concurrent use of prescription opioids and benzodiazepine/Z-drugs in Alberta, Canada: a population-based study
por: Sharma, Vishal, et al.
Publicado: (2019)

Safe opioid prescribing: a prognostic machine learning approach to predicting 30-day risk after an opioid dispensation in Alberta, Canada
por: Sharma, Vishal, et al.
Publicado: (2021)

Overpoliced and Underrepresented: Perspectives on Cannabis Legalization From Members of Racialized Communities in Canada
por: Wiese, Jessica L., et al.
Publicado: (2022)

Factorial Validity and Invariance of the 7-Item Generalized Anxiety Disorder Scale (GAD-7) Among Populations With and Without Self-Reported Psychiatric Diagnostic Status
por: Doi, Satomi, et al.
Publicado: (2018)

Psychometric analysis of the Generalized Anxiety Disorder scale (GAD-7) in primary care using modern item response theory
por: Jordan, Pascal, et al.
Publicado: (2017)

The impact of cannabis use on patients enrolled in opioid agonist therapy in Ontario, Canada
por: Franklyn, Alexandra M., et al.
Publicado: (2017)

PSYCHOMETRIC PROPERTIES OF THE POLISH VERSION OF THE GENERALIZED ANXIETY DISORDER 7-ITEM SCALE (GAD-7) IN A NON-CLINICAL SAMPLE OF EMPLOYEES DURING PANDEMIC CRISIS
por: Basińska, Beata Aleksandra, et al.
Publicado: (2023)

Using Generalized Anxiety Disorder-2 (GAD-2) and GAD-7 in a Primary Care Setting
por: Sapra, Amit, et al.
Publicado: (2020)

Validation of the generalized anxiety disorder scales (GAD-7 and GAD-2) in primary care settings in Latvia
por: Vrublevska, Jelena, et al.
Publicado: (2022)

The reliability, validity and factorial structure of the Swahili version of the 7-item generalized anxiety disorder scale (GAD-7) among adults living with HIV from Kilifi, Kenya
por: Nyongesa, Moses K., et al.
Publicado: (2020)

Incremental costs of hospital-acquired complications in Alberta, Canada
por: Jackson, T, et al.
Publicado: (2011)

Changes in Emergency Department Visits for Cannabis Hyperemesis Syndrome Following Recreational Cannabis Legalization and Subsequent Commercialization in Ontario, Canada
por: Myran, Daniel Thomas, et al.
Publicado: (2022)

Diagnostic Validity of the Generalized Anxiety Disorder - 7 (GAD-7) among Pregnant Women
por: Zhong, Qiu-Yue, et al.
Publicado: (2015)

Psychometric properties of the generalized anxiety disorder-7 (GAD-7) in a sample of workers
por: Merino-Soto, César, et al.
Publicado: (2023)

Measuring anxiety after spinal cord injury: Development and psychometric characteristics of the SCI-QOL Anxiety item bank and linkage with GAD-7
por: Kisala, Pamela A., et al.
Publicado: (2015)

Validity and reliability of the Generalized Anxiety Disorder-7 (GAD-7) among university students of Bangladesh
por: Dhira, Tahia Anan, et al.
Publicado: (2021)

A retrospective analysis of real-world use of the eaTracker® My Goals website by adults from Ontario and Alberta, Canada
por: Lieffers, Jessica R. L., et al.
Publicado: (2016)

SARS-CoV-2 Transmission in Alberta, British Columbia, and Ontario, Canada, December 25, 2019, to December 1, 2020
por: Fung, Isaac Chun-Hai, et al.
Publicado: (2021)

Outcomes Among Patients Hospitalized With Non–COVID-19 Conditions Before and During the COVID-19 Pandemic in Alberta and Ontario, Canada
por: McAlister, Finlay A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s809vdmr0f3okejhbbg9vllu9h